Skip to main content
PMC home page
Infection and Immunity logoLink to Infection and Immunity
. 1981 Sep;33(3):820–826. doi: 10.1128/iai.33.3.820-826.1981

Biological activities of crystalline pertussigen from Bordetella pertussis.

J J Munoz, H Arai, R K Bergman, P L Sadowski
PMCID: PMC350785  PMID: 6269999

Abstract

We studied various biological activities of crystalline pertussigen and found that in mice as little as 0.5 ng of pertussigen induced hypersensitivity to histamine, 8 to 40 ng induced leukocytosis, 2 ng increased production of insulin, 0.1 ng increased production of immunoglobulin E and immunoglobulin G1 antibodies to hen egg albumin, 9.5 ng increased susceptibility to anaphylactic shock, and 0.5 ng increased the vascular permeability of striated muscle. We also found that in Lewis rats 20 ng of pertussigen promoted the induction of hyperacute experimental allergic encephalomyelitis. Pertussigen given intraperitoneally was toxic to mice at a dose of 546 ng. Treatment of pertussigen with glutaraldehyde eliminated this toxicity. Mice immunized with 1,700 ng of detoxified pertussigen were protected against intracerebral challenge with 3 x 10(4) viable Bordetella pertussis cells. When as little as 0.5 ng of pertussigen was given intravenously to mice, the increased susceptibility of the animals to histamine could still be detected 84 days later. The biological properties of crystalline pertussigen indicate its similarity to leukocytosis-promoting factor, Islet-activating protein, late-appearing toxic factor, and mouse-protective antigen of B. pertussis.

Full text

PDF
820

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Arai H., Munoz J. J. Crystallization of pertussigen from Bordetella pertussis. Infect Immun. 1981 Jan;31(1):495–499. doi: 10.1128/iai.31.1.495-499.1981. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Arai H., Sato Y. Separation and characterization of two distinct hemagglutinins contained in purified leukocytosis-promoting factor from Bordetella pertussis. Biochim Biophys Acta. 1976 Oct 22;444(3):765–782. doi: 10.1016/0304-4165(76)90323-8. [DOI] [PubMed] [Google Scholar]
  3. Bergman R. K., Munoz J. J. Effect of Bordetella pertussis extract and vasoactive amines on vascular permeability. J Allergy Clin Immunol. 1975 Jun;55(6):378–385. doi: 10.1016/0091-6749(75)90076-7. [DOI] [PubMed] [Google Scholar]
  4. Bergman R. K., Munoz J. J., Portis J. L. Vascular permeability changes in the central nervous system of rats with hyperacute experimental allergic encephalomyelitis induced with the aid of a substance from Bordetella pertussis. Infect Immun. 1978 Aug;21(2):627–637. doi: 10.1128/iai.21.2.627-637.1978. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Clausen C. R., Munoz J., Bergman R. K. Reaginic-type of antibody in mice stimulated by extracts of Bordetella pertussis. J Immunol. 1969 Oct;103(4):768–777. [PubMed] [Google Scholar]
  6. FISHEL C. W., SZENTIVANYI A., TALMAGE D. W. Sensitization and desensitization of mice to histamine and serotonin by neurohumors. J Immunol. 1962 Jul;89:8–18. [PubMed] [Google Scholar]
  7. Ishizaka K. Cellular events in the IgE antibody response. Adv Immunol. 1976;23:1–75. doi: 10.1016/s0065-2776(08)60318-1. [DOI] [PubMed] [Google Scholar]
  8. Kurokawa M., Iwasa S., Ishida S. On a possible new kind of toxic substance produced by Bordetella pertussis. Jpn J Med Sci Biol. 1965 Jun;18(3):161–165. doi: 10.7883/yoken1952.18.161. [DOI] [PubMed] [Google Scholar]
  9. LOWRY O. H., ROSEBROUGH N. J., FARR A. L., RANDALL R. J. Protein measurement with the Folin phenol reagent. J Biol Chem. 1951 Nov;193(1):265–275. [PubMed] [Google Scholar]
  10. Leibowitz S., Kennedy L. Cerebral vascular permeability and cellular infiltration in experimental allergic encephalomyelitis. Immunology. 1972 May;22(5):859–869. [PMC free article] [PubMed] [Google Scholar]
  11. Levine S., Wenk E. J., Devlin H. B., Pieroni R. E., Levine L. Hyperacute allergic encephalomyelitis: adjuvant effect of pertussis vaccines and extracts. J Immunol. 1966 Sep;97(3):363–368. [PubMed] [Google Scholar]
  12. Morse S. I., Morse J. H. Isolation and properties of the leukocytosis- and lymphocytosis-promoting factor of Bordetella pertussis. J Exp Med. 1976 Jun 1;143(6):1483–1502. doi: 10.1084/jem.143.6.1483. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Munoz J. J., Arai H., Cole R. L. Mouse-protecting and histamine-sensitizing activities of pertussigen and fimbrial hemagglutinin from Bordetella pertussis. Infect Immun. 1981 Apr;32(1):243–250. doi: 10.1128/iai.32.1.243-250.1981. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Munoz J., Bergman R. K. Some histamine sensitizing properties of soluble preparations of the histamine sensitizing factor(HSF) from Bordetella pertussis. J Immunol. 1966 Jul;97(1):120–125. [PubMed] [Google Scholar]
  15. Ovary Z., Caiazza S. S., Kojima S. PCA reactions with mouse antibodies in mice and rats. Int Arch Allergy Appl Immunol. 1975;48(1):16–21. doi: 10.1159/000231289. [DOI] [PubMed] [Google Scholar]
  16. Sato Y., Arai H., Suzuki K. Leukocytosis-promoting factor of Bordetella pertussis. II. Biological properties. Infect Immun. 1973 Jun;7(6):992–999. doi: 10.1128/iai.7.6.992-999.1973. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Yajima M., Hosoda K., Kanbayashi Y., Nakamura T., Nogimori K., Mizushima Y., Nakase Y., Ui M. Islets-activating protein (IAP) in Bordetella pertussis that potentiates insulin secretory responses of rats. Purification and characterization. J Biochem. 1978 Jan;83(1):295–303. doi: 10.1093/oxfordjournals.jbchem.a131904. [DOI] [PubMed] [Google Scholar]

Articles from Infection and Immunity are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES